Acquired Haemophilia Recruiting Phase 3 Trials for Rituximab (DB00073)

Also known as: Acquired hemophilia / Autoimmune hemophilia

IndicationStatusPhase
DBCOND0032755 (Acquired Haemophilia)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01808911Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)Treatment